Recent Quotes
My Watchlist
Indicators
Local Stocks
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Citius Pharmaceuticals Inc (NQ: CTXR )

0.3707 -0.0020 (-0.54%)
Streaming Delayed Price Updated: 9:37 AM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Citius Pharmaceuticals Inc

< Previous 1 2 3 4 Next >
61 Biggest Movers From Yesterday
Gainers Vivakor, Inc. (NASDAQ: VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed a 10-year contract with Hot Oil Transport with... 
Via Benzinga
First Patient Dosed in Citius Pharma's Phase 2b Study of Halo-Lido for the Prescription Treatment of Hemorrhoids
Citius Pharmaceuticals, Inc. (NASDAQ: CTXR) announced enrolment of first patient in the Phase 2b clinical study of Halo-Lido for the treatment of hemorrhoids. 
Via Benzinga
Citius Pharma Reveals Topline Immunotherapy Data From Late-Stage Lymphoma Trial
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Healthcare Triangle (NASDAQ:HCTI) stock moved upwards by 17.5% to $1.35 during Wednesday's pre-market session. The company's market cap stands at $47.6... 
Via Benzinga
The Daily Biotech Pulse: BioXcel's Igalmi Gets FDA Nod, Citius Spikes On Positive Phase 3 Data, Iovance Receives Positive Regulatory Feedback For Skin Cancer Therapy
Here's a roundup of top developments in the biotech space over the last 24 hours. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Rhythm Pharmaceuticals (NASDAQ:RYTM) stock increased by 16.4% to $7.72 during Thursday's regular session. The current volume of 639.5K shares is 152.7% of... 
Via Benzinga
Penny Stock Watchlist - Here Are My Five Top Picks
If you got into Amazon at the start of 2021, by the end of 2021 you'd have made about 73% gains. Not bad for a year. It's impressive until you consider that one of these stocks made 258% gains in the... 
Via Talk Markets
FDA Signs Off Citius Pharma's Phase 2 Trial With Halo-Lido In Hemorrhoids
The FDA has issued a Study May Proceed letter for Citius Pharmaceuticals Inc's (NASDAQ: CTXR) Halo-Lido to treat hemorrhoids. The Company anticipates... 
Via Benzinga
Citius Pharmaceuticals: Q1 Earnings Insights
Citius Pharmaceuticals (NASDAQ:CTXR) reported its Q1 earnings results on Thursday, February 10, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Citius... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2021
Upgrades Sidoti & Co. upgraded the previous rating for DMC Global Inc (NASDAQ: 
Via Benzinga
Why This Citius Analyst Thinks The Biopharma's Shares Present 375% Upside Potential
Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) 
Via Benzinga
Citius Pharmaceuticals Addresses Unmet Needs for Patients with CVCs
Image by falco from Pixabay What happens when the one product keeping you alive becomes infected? Central venous catheters (CVCs) are important life lines for treating many... 
Via Benzinga
Could Citius Pharmaceuticals Be a Millionaire-Maker Stock?
A lot would have to go right for this biotech to make investors rich. 
Via The Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers Alector (NASDAQ:ALEC) shares moved upwards by 52.47% to $34.17 during Friday's regular session. Alector's stock is trading at a volume of 26.9 million... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Alector (NASDAQ:ALEC) stock moved upwards by 39.93% to $31.36 during Friday's pre-market session. The market value of their outstanding shares is at $2.5... 
Via Benzinga
56 Biggest Movers From Friday
Gainers Sequential Brands Group, Inc. (NASDAQ: SQBG) jumped 89.2% to settle at $15.70. Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 73.2% to close at $18.79. A 13G... 
Via Benzinga
24 Stocks Moving in Friday's Pre-Market Session
Gainers T.A.T. Technologies Ltd. (NASDAQ: TATT) shares rose 53.4% to $9.09 in pre-market trading after the company announced a new MRO partnership with Honeywell. Staffing 360... 
Via Benzinga
58 Biggest Movers From Yesterday
Gainers The Glimpse Group, Inc. (NASDAQ: VRAR) shares jumped 152.3% to settle at $17.66 on Thursday after the company priced its IPO at $7 per share. Pop Culture Group Co., Ltd (... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Mid-Afternoon Market Update: Dow Gains 100 Points; NovoCure Shares Plunge
Toward the end of trading Thursday, the Dow traded up 0.29% to 34,603 while the NASDAQ rose 0.01% to 14,504.68. The S&P also rose, gaining 0.44% to 4,316.39. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures US Equities
Here's Why Citius Pharmaceuticals Stock Is Losing Ground Today
Another interim analysis has come and gone with an unsatisfying result. 
Via The Motley Fool
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers Alterity Therapeutics (NASDAQ:ATHE 
Via Benzinga
Mid-Day Market Update: Crude Oil Rises Over 2%; Aligos Therapeutics Shares Slide
Midway through trading Thursday, the Dow traded up 0.20% to 34,571.92 while the NASDAQ fell 0.24% to 14,468.72. The S&P also rose, gaining 0.24% to 4,307.60 The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
30 Stocks Moving In Thursday's Mid-Day Session
Gainers Pop Culture Group Co., Ltd (NASDAQ: CPOP) shares jumped 104.6% to $62.00. Pop Culture Group shares jumped 405% on Wednesday after the company priced its IPO at $6 per... 
Via Benzinga
Topics Initial Public Offering
Exposures Securities Market
Mid-Morning Market Update: Markets Open Higher; Walgreens Posts Q3 Profit
Following the market opening Thursday, the Dow traded up 0.18% to 34,565.67 while the NASDAQ rose 0.08% to 14,515.51. The S&P also rose, gaining 0.28% to 4,309.37. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
The Week Ahead In Biotech: Mediwound, Provention FDA Decisions, IPOs, Pending Clinical Readouts In Focus
Biotech stocks reversed course and closed the week ended June 25 higher, thanks to the positive broader market sentiment. Eli Lilly and Company (NYSE: LLY) stood out among big... 
Via Benzinga
Exposures Product Safety
Is It Too Late to Buy Citius Pharmaceuticals Stock?
See if this biotech has what takes to climb even higher. 
Via The Motley Fool
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Anavex Life Sciences (NASDAQ:AVXL) stock increased by 17.07% to $25.92 during Tuesday's regular session. As of 12:33 EST, this security is trading at a volume... 
Via Benzinga
The Daily Biotech Pulse: Lilly Spikes On Alzheimer's Drug Regulatory Filing Plan, Applied Genetics, Arcus Issue Data Readouts, Adcom Test Awaits Incyte, Monte Rosa Prices IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 23) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
Stocks That Hit 52-Week Highs On Tuesday
Before 10 a.m. ET Tuesday, 59 stocks made new 52-week highs. Intriguing Points: Microsoft (NASDAQ:MSFT) was the company with the largest market cap to set a new 52-week... 
Via Benzinga
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.